Vitamin D analogs differentially control antimicrobial peptide/"alarmin" expression in psoriasis

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  Peric, Mark ^a   Koglin, Sarah ^a   Dombrowski, Yvonne ^a   Groß, Katrin ^a   Bradac, Eva ^a   Büchau, Amanda ^a   Steinmeyer, Andreas ^b   Zügel, Ulrich ^b   Ruzicka, Thomas ^a   Schauber, Jürgen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,24 TRIHYDROXY 26,27 CYCLO 9,10 SECOCHOLESTA 5,7,10(19),22 TETRAENE 25 CARBOXYLIC ACID BUTYL ESTER; ADENOSINE PHOSPHATE; ALARMIN; BETA DEFENSIN 2; BETA DEFENSIN 3; CALCIPOTRIOL; CALCITRIOL; CATHELICIDIN; CYTOKINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; POLYPEPTIDE ANTIBIOTIC AGENT; PSORIASIN; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR; ZK 191784; ZK 203278; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; CALCITRIOL RECEPTOR; CAP18 LIPOPOLYSACCHARIDE BINDING PROTEIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; DRUG DERIVATIVE; PEPTIDE; VITAMIN D;

ARTICLE; CELL CULTURE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; KERATINOCYTE; PROTEIN EXPRESSION; PSORIASIS; PSORIASIS VULGARIS; SIGNAL TRANSDUCTION; SKIN DEFECT; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; POLYMERASE CHAIN REACTION; REPORTER GENE; RNA INTERFERENCE; WESTERN BLOTTING;

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOTTING, WESTERN; CELLS, CULTURED; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; INTERLEUKIN-17; INTERLEUKIN-8; MAP KINASE SIGNALING SYSTEM; PEPTIDES; POLYMERASE CHAIN REACTION; PSORIASIS; RECEPTORS, CALCITRIOL; RNA INTERFERENCE; VITAMIN D;

EID: 67749111996     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006340     Document Type: Article

References (45)

1. Hollox EJ, Huffmeier U, Zeeuwen PL, Palla R, Lascorz J, et al. (2008) Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 40: 23-25.
2. McCarroll SA (2008) Copy-number analysis goes more than skin deep. Nat Genet 40: 5-6.
3. Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445: 866-873.
4. Schauber J, Gallo RL (2008) Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 122: 261-266.
5. Oppenheim JJ, Tewary P, de la Rosa G, Yang D (2007) Alarmins initiate host defense. Adv Exp Med Biol 601: 185-194.
6. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, et al. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347: 1151-1160.
7. Gambichler T, Skrygan M, Tomi NS, Othlinghaus N, Brockmeyer NH, et al. (2008) Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int Arch Allergy Immunol 147: 17-24.
8. Zheng Y, Niyonsaba F, Ushio H, Ikeda S, Nagaoka I, et al. (2008) Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation. Immunology 124: 357-367.
9. Glaser R, Meyer-Hoffert U, Harder J, Cordes J, Wittersheim M, et al. (2009) The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 129: 641-649.
10. Chamorro CI, Weber G, Gronberg A, Pivarcsi A, Stahle M (2008) The Human Antimicrobial Peptide LL-37 Suppresses Apoptosis in Keratinocytes. J Invest Dermatol.
11. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, et al. (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449: 564-569.
12. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, et al. (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8: 950-957.
13. Boniface K, Guignouard E, Pedretti N, Garcia M, Delwail A, et al. (2007) A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin Exp Immunol 150: 407-415.
14. Arican O, Aral M, Sasmaz S, Ciragil P (2005) Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005. pp 273-279.
15. Caproni M, Antiga E, Melani L, Volpi W, Del Bianco E, et al. (2009) Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial. J Clin Immunol 29: 210-214.
16. Wolk K, Witte E, Wallace E, Docke WD, Kunz S, et al. (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36: 1309-1323.
17. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, et al. (2004) IL-22 increases the innate immunity of tissues. Immunity 21: 241-254.
18. Kao CY, Chen Y, Thai P, Wachi S, Huang F, et al. (2004) IL-17 markedly upregulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol 173: 3482-3491.
19. Kao CY, Kim C, Huang F, Wu R (2008) Requirements for two proximal NF-kappaB binding sites and IkappaB-zeta in IL-17A-induced human beta-defensin 2 expression by conducting airway epithelium. J Biol Chem 283: 15309-15318.
20. Wang T-T, Nestel F, Bourdeau V, Nagai Y, Wang Q, et al. (2004) Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression. J Immunol 173: 2909-2912.
21. Schauber J, Dorschner RA, Yamasaki K, Brouha B, Gallo RL (2006) Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology 118: 509-519.
22. Schauber J, Dorschner RA, Coda AB, Buchau AS, Liu PT, et al. (2007) Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117: 803-811.
23. Peric M, Koglin S, Kim SM, Morizane S, Besch R, et al. (2008) IL-17A Enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J Immunol 181: 8504-8512.
24. Duweb G, Alhaddar J, Abuhamida M (2005) Calcipotriol solution in scalp psoriasis. Int J Tissue React 27: 163-166.
25. Charakida A, Dadzie O, Teixeira F, Charakida M, Evangelou G, et al. (2006) Calcipotriol/betamethasone dipropionate for the treatment of psoriasis. Expert Opin Pharmacother 7: 597-606.
26. Fogh K, Kragballe K (1997) Vitamin D3 analogues. Clin Dermatol 15: 705-713.
27. Frohm M, Agerberth B, Ahangari G, Stahle-Backdahl M, Liden S, et al. (1997) The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 272: 15258-15263.
28. van Beelen AJ, Teunissen MB, Kapsenberg ML, de Jong EC (2007) Interleukin-17 in inflammatory skin disorders. Curr Opin Allergy Clin Immunol 7: 374-381.
29. Ghosh S, Hayden MS (2008) New regulators of NF-kappaB in inflammation. Nat Rev Immunol 8: 837-848.
30. Schauber J, Oda Y, Buchau AS, Yun QC, Steinmeyer A, et al. (2008) Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-Dihydroxyvitamin D(3). J Invest Dermatol 128: 816-824.
31. Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Suarez-Farinas M, et al. (2007) Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 204: 3183-3194.
32. Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Abello MV, Novitskaya I, et al. (2009) Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 129: 79-88.
33. Riis JL, Johansen C, Gesser B, Moller K, Larsen CG, et al. (2004) 1alpha,25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaBalpha expression. Arch Dermatol Res 296: 195-202.
34. van der Vleuten CJ, de Jong EM, van de Kerkhof PC (1996) Epidermal differentiation characteristics of the psoriatic plaque during treatment with calcipotriol. Arch Dermatol Res 288: 366-372.
35. Schittek B, Paulmann M, Senyurek I, Steffen H (2008) The role of antimicrobial peptides in human skin and in skin infectious diseases. Infect Disord Drug Targets 8: 135-143.
36. Watanabe H, Kawaguchi M, Fujishima S, Ogura M, Matsukura S, et al. (2009) Functional characterization of IL-17F as a selective neutrophil attractant in psoriasis. J Invest Dermatol 129: 650-656.
37. Penna G, Amuchastegui S, Giarratana N, Daniel KC, Vulcano M, et al. (2007) 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol 178: 145-153.
38. Brown AJ, Slatopolsky E (2008) Vitamin D analogs: therapeutic applications and mechanisms for selectivity. Mol Aspects Med 29: 433-452.
39. Carlberg C (2003) Molecular basis of the selective activity of vitamin D analogues. J Cell Biochem 88: 274-281.
40. Nijenhuis T, van der Eerden BC, Zugel U, Steinmeyer A, Weinans H, et al. (2006) The novel vitamin D analog ZK191784 as an intestine-specific vitamin D antagonist. Faseb J 20: 2171-2173.
41. Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, et al. (2006) Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 36: 361-370.
42. Toell A, Gonzalez MM, Ruf D, Steinmeyer A, Ishizuka S, et al. (2001) Different molecular mechanisms of vitamin D(3) receptor antagonists. Mol Pharmacol 59: 1478-1485.
43. Zugel U, Steinmeyer A, Giesen C, Asadullah K (2002) A novel immunosuppressive 1alpha,25-dihydroxyvitamin D3 analog with reduced hypercalcemic activity. J Invest Dermatol 119: 1434-1442.
44. Peric M, Koglin S, Ruzicka T, Schauber J (2009) [Cathelicidins: multifunctional defense molecules of the skin]. Dtsch Med Wochenschr 134: 35-38.
45. Hata TR, Kotol P, Jackson M, Nguyen M, Paik A, et al. (2008) Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy Clin Immunol 122: 829-831.